An antibiotic is a chemical compound that kills or slows down the growth of any disease-causing microorganisms such as bacteria, parasite, and fungi but is not effective against viruses and prions. The term antibiotic was originally coined to refer to any compound of microbial origin that is antagonistic to the growth of the microbe. Antibiotics act via various mechanisms such as the inhibition of cell wall synthesis, the inhibition of nucleic acid synthesis, the disruption of the cell membrane, and the inhibition of protein synthesis.

Technavio’s analysts forecast the global antibiotics market to grow at a CAGR of 2.16% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global antibiotics market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

Technavio's report, Global Antibiotics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

Allergan

GlaxoSmithKline

Merck

Pfizer

Other prominent vendors

Abbott

Achaogen

Actelion Pharmaceuticals

AmpliPhi Biosciences

Aspen Pharmacare

Astellas Pharma

AstraZeneca

Aurobindo Pharma

Baxter

Basilea Pharmaceutica

Bayer HealthCare

Biocon

Bristol-Myers Squibb

Cempra

Cipher Pharmaceuticals

CordenPharma

Chiesi Farmaceutici

Eli Lilly

Exoxemis

F. Hoffmann-La Roche

Flynn Pharma

Incepta Pharmaceuticals

InSite Vision

Insmed

Johnson & Johnson

Humanigen

Kyorin Pharmaceutical

Lupin Pharmaceuticals

Lytix Biopharma

Melinta Therapeutics

Mylan

Nektar

Orchid Pharma

Par Pharmaceutical

Paratek Pharmaceuticals

Pernix Therapeutics

PTC Therapeutics

RedHill

Sagent Pharmaceuticals

Sanofi

Shionogi

Starpharma

Sun Pharmaceutical

Symbiomix

Takeda Pharmaceutical

Tetraphase Pharmaceuticals

Theravance Biopharma

The Medicines Company

Valneva

Wockhardt

Market driver

Rising prevalence of infectious diseases

For a full, detailed list, view our report

Market challenge

Development of antibiotic-resistant strains

For a full, detailed list, view our report

Market trend

Strategic alliances and mergers and acquisitions (M&A)

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2021 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

Press Release

Technavio Announces the Publication of its Research Report – Global Antibiotics Market 2017-2021

Technavio recognizes the following companies as the key players in the global antibiotics market: Allergan, GlaxoSmithKline, Merck, and Pfizer.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Strategic alliances and mergers and acquisitions (M&A). Formation of strategic alliances, in terms of licensing and collaboration, help in the co-development and commercialization of drugs in different regions. Co-development agreements between different companies enable the use of technical expertize from both companies. These agreements also allow the use of regulatory and development experience gained by one company for the support of pipeline candidates of another company.”

According to the report, one of the major drivers for this market is Rising prevalence of infectious diseases. Globally, there has been an increase in the number individuals affected by infectious diseases. Infectious diseases are caused by pathogens and can be transmitted from one person to another through direct or indirect contact. Thus, factors that favor the growth and transmission of these pathogens contribute to the spread of infectious diseases. Demographic changes caused by increased globalization and urbanization are a major factor leading to the global emergence of infectious diseases.

Further, the report states that one of the major factors hindering the growth of this market is Development of antibiotic-resistant strains. The development of multidrug-resistant microbes is one of the major threats to the human health in the present days. The microbe changes itself to protect against the antimicrobial agent used and thereby develops resistance to the drug. The antibiotic resistance usually develops due to the irrational use of these drugs.